104 related articles for article (PubMed ID: 2726493)
21. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes.
Grant DM; Blum M; Beer M; Meyer UA
Mol Pharmacol; 1991 Feb; 39(2):184-91. PubMed ID: 1996083
[TBL] [Abstract][Full Text] [Related]
22. Cloning and nucleotide sequence of the gene for dihydrolipoamide acetyltransferase from Saccharomyces cerevisiae.
Niu XD; Browning KS; Behal RH; Reed LJ
Proc Natl Acad Sci U S A; 1988 Oct; 85(20):7546-50. PubMed ID: 3050999
[TBL] [Abstract][Full Text] [Related]
23. [Partial separation of allelic forms of N-acetyltransferase from the rabbit liver using a new method of enzyme purification].
Kabishev AA; Patrushev LI
Biokhimiia; 1987 May; 52(5):761-71. PubMed ID: 3593799
[TBL] [Abstract][Full Text] [Related]
24. Diverse point mutations in the human gene for polymorphic N-acetyltransferase.
Vatsis KP; Martell KJ; Weber WW
Proc Natl Acad Sci U S A; 1991 Jul; 88(14):6333-7. PubMed ID: 2068113
[TBL] [Abstract][Full Text] [Related]
25. The putative tumour suppressor Fus-2 is an N-acetyltransferase.
Zegerman P; Bannister AJ; Kouzarides T
Oncogene; 2000 Jan; 19(1):161-3. PubMed ID: 10644992
[TBL] [Abstract][Full Text] [Related]
26. An N-ethyl-N-nitrosourea-induced mutation in N-acetyltransferase 1 in mice.
Erickson RP; McQueen CA; Chau B; Gokhale V; Uchiyama M; Toyoda A; Ejima F; Maho N; Sakaki Y; Gondo Y
Biochem Biophys Res Commun; 2008 May; 370(2):285-8. PubMed ID: 18373979
[TBL] [Abstract][Full Text] [Related]
27. Extrahepatic expression of N-acetylator genotype in the inbred hamster.
Hein DW; Kirlin WG; Ogolla F; Trinidad A
Drug Metab Dispos; 1987; 15(1):68-73. PubMed ID: 2881761
[TBL] [Abstract][Full Text] [Related]
28. Arylamine N-acetyltransferase in Balb/c mice: identification of a novel mouse isoenzyme by cloning and expression in vitro.
Kelly SL; Sim E
Biochem J; 1994 Sep; 302 ( Pt 2)(Pt 2):347-53. PubMed ID: 7545952
[TBL] [Abstract][Full Text] [Related]
29. [Molecular pharmacology of polymorphic arylamine N-acetyltransferase involved in the metabolism of arylamine drugs].
Deguchi T
Nihon Rinsho; 1992 Apr; 50(4):877-86. PubMed ID: 1619774
[TBL] [Abstract][Full Text] [Related]
30. Arylamine N-acetyltransferases. Expression in Escherichia coli, purification, and substrate specificities of recombinant hamster monomorphic and polymorphic isozymes.
Wagner CR; Bergstrom CP; Koning KR; Hanna PE
Drug Metab Dispos; 1996 Feb; 24(2):245-53. PubMed ID: 8742238
[TBL] [Abstract][Full Text] [Related]
31. Cloning and molecular characterization of three arylamine N-acetyltransferase genes from Bacillus anthracis: identification of unusual enzymatic properties and their contribution to sulfamethoxazole resistance.
Pluvinage B; Dairou J; Possot OM; Martins M; Fouet A; Dupret JM; Rodrigues-Lima F
Biochemistry; 2007 Jun; 46(23):7069-78. PubMed ID: 17511472
[TBL] [Abstract][Full Text] [Related]
32. Acetylation pharmacogenetics. The slow acetylator phenotype is caused by decreased or absent arylamine N-acetyltransferase in human liver.
Grant DM; Mörike K; Eichelbaum M; Meyer UA
J Clin Invest; 1990 Mar; 85(3):968-72. PubMed ID: 2312737
[TBL] [Abstract][Full Text] [Related]
33. [The mechanism of in vivo arylamine acetyltransferase activation].
Ksenzenko SM; Ksenzenko MIu
Nauchnye Doki Vyss Shkoly Biol Nauki; 1990; (1):19-24. PubMed ID: 2346768
[TBL] [Abstract][Full Text] [Related]
34. Acetylator phenotype-dependent and -independent expression of arylamine N-acetyltransferase isozymes in rapid and slow acetylator inbred rat liver.
Hein DW; Rustan TD; Bucher KD; Martin WJ; Furman EJ
Drug Metab Dispos; 1991; 19(5):933-7. PubMed ID: 1686239
[TBL] [Abstract][Full Text] [Related]
35. Purification, physicochemical, and kinetic properties of liver acetyl-CoA:arylamine N-acetyltransferase from rapid acetylator rabbits.
Andres HH; Vogel RS; Tarr GE; Johnson L; Weber WW
Mol Pharmacol; 1987 Apr; 31(4):446-56. PubMed ID: 3574290
[TBL] [Abstract][Full Text] [Related]
36. N-hydroxyarylamine O-acetyltransferase of Salmonella typhimurium: proposal for a common catalytic mechanism of arylamine acetyltransferase enzymes.
Watanabe M; Igarashi T; Kaminuma T; Sofuni T; Nohmi T
Environ Health Perspect; 1994 Oct; 102 Suppl 6(Suppl 6):83-9. PubMed ID: 7889864
[TBL] [Abstract][Full Text] [Related]
37. DNA damage induces N-acetyltransferase NAT10 gene expression through transcriptional activation.
Liu H; Ling Y; Gong Y; Sun Y; Hou L; Zhang B
Mol Cell Biochem; 2007 Jun; 300(1-2):249-58. PubMed ID: 17180247
[TBL] [Abstract][Full Text] [Related]
38. Genetic control of acetyl coenzyme A-dependent arylamine N-acetyltransferase, hydrazine N-acetyltransferase, and N-hydroxy-arylamine O-acetyltransferase enzymes in C57BL/6J, A/J, AC57F1, and the rapid and slow acetylator A.B6 and B6.A congenic inbred mouse.
Hein DW; Trinidad A; Yerokun T; Ferguson RJ; Kirlin WG; Weber WW
Drug Metab Dispos; 1988; 16(3):341-7. PubMed ID: 2900723
[TBL] [Abstract][Full Text] [Related]
39. Pharmacogenetics of the arylamine N-acetyltransferases.
Butcher NJ; Boukouvala S; Sim E; Minchin RF
Pharmacogenomics J; 2002; 2(1):30-42. PubMed ID: 11990379
[TBL] [Abstract][Full Text] [Related]
40. Identification of single-nucleotide polymorphisms (SNPs) of human N-acetyltransferase genes NAT1, NAT2, AANAT, ARD1 and L1CAM in the Japanese population.
Sekine A; Saito S; Iida A; Mitsunobu Y; Higuchi S; Harigae S; Nakamura Y
J Hum Genet; 2001; 46(6):314-9. PubMed ID: 11393533
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
